Biomarkers of pulmonary rejection

Transplantation Proceedings

Volumn 45, Issue 9, 2013, Pages 3163-3169

  Berastegui, C ^a,b   Roman J ^a,b   Monforte, V ^a,b   Bravo, C ^a,b   Lopez Meseguer M ^a,b   Montero, M A ^c   Culebras, M ^a,b   Gomez Olles S ^a,b   Roman A ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BILE ACID; BIOLOGICAL MARKER; BRONCHODILATING AGENT; CHEMOKINE RECEPTOR CCR2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

AIRWAY OBSTRUCTION; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; LONG TERM SURVIVAL; LUNG GRAFT REJECTION; MONONUCLEAR PHAGOCYTE; PRIORITY JOURNAL; TOTAL LUNG CAPACITY; TRANSBRONCHIAL BIOPSY;

BIOLOGICAL MARKERS; CYTOKINES; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION;

EID: 84887061045     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.06.013     Document Type: Article

References (54)

1. J.D. Christie, L.B. Edwards, and A.Y. Kucheryavaya The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report-2011 J Heart Lung Transplant 30 10 2011 1104 1122
2. E.A. Kastelijn, G.T. Rijkers, and C.H. Van Moorsel Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome J Heart Lung Transplant 29 9 2010 997 1008
3. S. Geleff, D. Draganovici, and P. Jaksch The role of chemokine receptors in acute lung allograft rejection Eur Respir J 35 1 2010 167 175
4. T. Martinu, D.N. Howell, and S.M. Palmer Acute cellular rejection and humoral sensitization in lung transplant recipients Semin Respir Crit Care Med 31 2 2010 179 188
5. G.M. Verleden, R. Vos, and S.I. De Vleeschauwer Obliterative bronchiolitis following lung transplantation: from old to new concepts? Transpl Int 22 8 2009 771 779
6. M. Sato, T.K. Waddell, and U. Wagnetz Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction J Heart Lung Transplant 30 7 2011 735 742
7. I. Paradis, H. Rabinowich, and A. Zeevi Life in the allogeneic environment after lung transplantation Lung 168 suppl 1990 1172 1181
8. S. Stewart, M.C. Fishbein, and G.I. Snell Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection J Heart Lung Transplant 26 12 2007 1229 1242
9. A.L. Gregson, A. Hoji, and R. Saggar Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection Transplantation 85 7 2008 1056 1059
10. B.M. Vanaudenaerde, L.J. Dupont, and W.A. Wuyts The role of interleukin-17 during acute rejection after lung transplantation Eur Respir J 27 4 2006 779 787
11. S.M. Bhorade, A. Yu, and W.T. Vigneswaran Elevation of interleukin-15 protein expression in bronchoalveolar fluid in acute lung allograft rejection Chest 131 2 2007 533 538
12. D.J. Ross, A. Moudgil, and A. Bagga Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage J Heart Lung Transplant 18 7 1999 627 636
13. J. Patil, J.D. Lande, and N. Li Bronchoalveolar lavage cell gene expression in acute lung rejection: development of a diagnostic classifier Transplantation 85 2 2008 224 231
14. S. Aharinejad, S. Taghavi, and W. Klepetko Prediction of lung-transplant rejection by hepatocyte growth factor Lancet 363 9420 2004 1503 1508
15. S.M. Bhorade, K. Janata, and W.T. Vigneswaran Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection J Heart Lung Transplant 27 9 2008 990 994
16. R.J. Kowalski, D.R. Post, and R.B. Mannon Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay Transplantation 82 5 2006 663 668
17. G.M. Verleden, L.J. Dupont, and D.E. Van Raemdonck Accuracy of exhaled nitric oxide measurements for the diagnosis of bronchiolitis obliterans syndrome after lung transplantation Transplantation 78 5 2004 730 733
18. R. Hachem, V. Tiriveedhi, and A. Patterson Pre-transplant antibodies to self-antigens and the subsequent development of donor-specific HLA antibodies after lung transplantation J Heart Lung Transplant 31 2012 S103
19. J.Z. Appel III, M.G. Hartwig, and R.D. Davis Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens Hum Immunol 66 4 2005 378 386
20. J.L. Todd, and S.M. Palmer Bronchiolitis obliterans syndrome: the final frontier for lung transplantation Chest 140 2 2011 502 508
21. C.M. Magro, A.E. Abbas, and K. Seilstad C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction Hum Immunol 67 4-5 2006 274 283
22. G.P. Westall, G.I. Snell, and C. McLean C3d and C4d deposition early after lung transplantation J Heart Lung Transplant 27 7 2008 722 728
23. W.D. Wallace, E.F. Reed, and D. Ross C4d staining of pulmonary allograft biopsies: an immunoperoxidase study J Heart Lung Transplant 24 10 2005 1565 1570
24. G. Solgi, D. Furst, and J. Mytilineos Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA Transpl Immunol 26 2-3 2012 81 87
25. C.M. Burton, J. Carlsen, and J. Mortensen Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome J Heart Lung Transplant 26 7 2007 681 686
26. M. Estenne, J.R. Maurer, and A. Boehler Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria J Heart Lung Transplant 21 3 2002 297 310
27. J.A. Belperio, S.S. Weigt, and M.C. Fishbein Chronic lung allograft rejection: mechanisms and therapy Proc Am Thorac Soc 6 1 2009 108 121
28. B.M. Vanaudenaerde, I. Meyts, and R. Vos A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Eur Respir J 32 4 2008 832 843
29. J.A. Belperio, B. DiGiovine, and M.P. Keane Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients Transplantation 73 4 2002 591 599
30. A. Moudgil, A. Bagga, and M. Toyoda Expression of gamma-IFN mRNA in bronchoalveolar lavage fluid correlates with early acute allograft rejection in lung transplant recipients Clin Transplant 13 2 1999 201 207
31. F. Meloni, P. Vitulo, and A. Cascina Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome J Heart Lung Transplant 23 9 2004 1053 1060
32. H.X. Zheng, G.J. Burckart, and K. McCurry Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation J Heart Lung Transplant 23 5 2004 541 546
33. M.P. Keane, B.N. Gomperts, and S. Weigt IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome J Immunol 178 1 2007 511 519
34. R. Vos, B.M. Vanaudenaerde, and S.E. Verleden Bronchoalveolar lavage neutrophilia in acute lung allograft rejection and lymphocytic bronchiolitis J Heart Lung Transplant 29 11 2010 1259 1269
35. J.N. Walter, L.L. Fan, and R. Bag Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation Transplantation 82 5 2006 709 711
36. A. El-Gamel, E. Sim, and P. Hasleton Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation J Heart Lung Transplant 18 9 1999 828 837
37. B.M. Vanaudenaerde, S.I. De Vleeschauwer, and R. Vos The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation Am J Transplant 8 9 2008 1911 1920
38. S. Yoshida, A. Haque, and T. Mizobuchi Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants Am J Transplant 6 4 2006 724 735
39. W.J. Burlingham, R.B. Love, and E. Jankowska-Gan IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants J Clin Invest 117 11 2007 3498 3506
40. A. Bharat, K. Narayanan, and T. Street Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection Transplantation 83 2 2007 150 158
41. T.A. Goers, S. Ramachandran, and A. Aloush De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection J Immunol 180 7 2008 4487 4494
42. J.A. Belperio, M.D. Burdick, and M.P. Keane The role of the CC chemokine, RANTES, in acute lung allograft rejection J Immunol 165 1 2000 461 472
43. J.A. Belperio, M.P. Keane, and M.D. Burdick Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome J Immunol 169 2 2002 1037 1049
44. J.A. Belperio, M.P. Keane, and M.D. Burdick Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome J Clin Invest 108 4 2001 547 556
45. J.A. Belperio, M.P. Keane, and M.D. Burdick Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome J Clin Invest 115 5 2005 1150 1162
46. J.M. Charpin, M. Stern, and D. Grenet Insulinlike growth factor-1 in lung transplants with obliterative bronchiolitis Am J Respir Crit Care Med 161 6 2000 1991 1998
47. L.D. Snyder, and S.M. Palmer Toll-like receptors, innate immunity and lung transplantation Front Biosci (Elite Ed) 1 2009 600 604
48. S.M. Palmer, L.H. Burch, and R.D. Davis The role of innate immunity in acute allograft rejection after lung transplantation Am J Respir Crit Care Med 168 6 2003 628 632
49. S.M. Palmer, L.H. Burch, and A.J. Trindade Innate immunity influences long-term outcomes after human lung transplant Am J Respir Crit Care Med 171 7 2005 780 785
50. S.M. Palmer, W. Klimecki, and L. Yu Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14 Am J Transplant 7 3 2007 693 699
51. A.S. Jackson, A. Sandrini, and C. Campbell Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage Am J Respir Crit Care Med 175 3 2007 222 227
52. V. Mertens, K. Blondeau, and O.L. Van Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin Am J Transplant 11 2 2011 329 335
53. F. Meloni, P. Vitulo, and A.M. Bianco Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome Transplantation 77 5 2004 762 766
54. S.M. Bhorade, H. Chen, and L. Molinero Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome Transplantation 90 5 2010 540 546